UFP Technologies’s (NASDAQ:UFPT) Q2 CY2026: Strong Sales, Stock Soars
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 15.1% year on year to $174 million. Its non-GAAP profit of $2.92 per share was 14.2% above analysts’ consensus estimates.
Is now the time to buy UFP Technologies? Find out by accessing our full research report, it’s free.
UFP Technologies (UFPT) Q2 CY2026 Highlights:
- Revenue: $174 million vs analyst estimates of $159.4 million (15.1% year-on-year growth, 9.1% beat)
- Adjusted EPS: $2.92 vs analyst estimates of $2.56 (14.2% beat)
- Adjusted EBITDA: $36.39 million vs analyst estimates of $32.65 million (20.9% margin, 11.5% beat)
- Operating Margin: 16.2%, in line with the same quarter last year
- Market Capitalization: $1.97 billion
Company Overview
With expertise dating back to 1963 in specialized materials and precision manufacturing, UFP Technologies (NASDAQ:UFPT) designs and manufactures custom solutions for medical devices, sterile packaging, and other highly engineered products for healthcare and industrial applications.
Revenue Growth
A company’s long-term performance is an indicator of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Over the last five years, UFP Technologies grew its sales at an exceptional 27.5% compounded annual growth rate. Its growth beat the average healthcare company and shows its offerings resonate with customers.
Long-term growth is the most important, but within healthcare, a half-decade historical view may miss new innovations or demand cycles. UFP Technologies’s annualized revenue growth of 23% over the last two years is below its five-year trend, but we still think the results suggest healthy demand. 
This quarter, UFP Technologies reported year-on-year revenue growth of 15.1%, and its $174 million of revenue exceeded Wall Street’s estimates by 9.1%.
Looking ahead, sell-side analysts expect revenue to grow 4.3% over the next 12 months, a deceleration versus the last two years. This projection is underwhelming and indicates its products and services will see some demand headwinds.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
Adjusted Operating Margin
UFP Technologies has managed its cost base well over the last five years. It demonstrated solid profitability for a healthcare business, producing an average adjusted operating margin of 16.4%.
Looking at the trend in its profitability, UFP Technologies’s adjusted operating margin rose by 5 percentage points over the last five years, as its sales growth gave it operating leverage.
This quarter, UFP Technologies generated an adjusted operating margin profit margin of 18%, in line with the same quarter last year. This indicates the company’s overall cost structure has been relatively stable.
Earnings Per Share
We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.
UFP Technologies’s EPS grew at 36.7% compounded annual growth rate over the last five years, higher than its 27.5% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.
Diving into the nuances of UFP Technologies’s earnings can give us a better understanding of its performance. As we mentioned earlier, UFP Technologies’s adjusted operating margin was flat this quarter but expanded by 5 percentage points over the last five years. This was the most relevant factor (aside from the revenue impact) behind its higher earnings; interest expenses and taxes can also affect EPS but don’t tell us as much about a company’s fundamentals.
In Q2, UFP Technologies reported adjusted EPS of $2.92, up from $2.50 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects UFP Technologies’s full-year EPS to grow 5.4% from $10.23 to $10.78.
Key Takeaways from UFP Technologies’s Q2 Results
We were impressed by how significantly UFP Technologies blew past analysts’ revenue expectations this quarter. We were also glad its EPS outperformed Wall Street’s estimates. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 5.3% to $281.50 immediately following the results.
UFP Technologies put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here (it’s free).